Healthcare - Press Releases

SAN DIEGO, Feb. 21, 2025 /PRNewswire/ --Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced that onFebruary 20, 2025,the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 107,000 shares of its common stock and 53,500 restricted stock units ("RSUs") to twenty-two (22) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).

KING OF PRUSSIA, Pa., Feb. 21, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences:

LAKELAND, Fla., Feb. 21, 2025 /PRNewswire/ -- Florida Southern College is thrilled to announce a new articulation agreement for Pre-Medical students with the Orlando College of Osteopathic Medicine (OCOM).

MARLBOROUGH, Mass., Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned finance subsidiary, has priced a public offering of EUR850,000,000 aggregate principal amount of 3.000% notes due 2031 and EUR650,000,000 aggregate principal amount of 3.250% notes due 2034 (collectively, the "Notes"). The Notes will be fully and unconditionally guaranteed by the Company. The offering is being made pursuant to a registration statement filed with the U.S. Securities and Exchange Commission.

Food Safety Advocate Questions Why Foodborne Illness Outbreaks are Unreported by thePremier Public Health Agency in the Time of Trump

THON Reaches Remarkable Financial Milestone After 46-Hour No-Sitting, No-Sleeping Dance Marathon Raises $17.7 Million for Families Affected by Childhood Cancer

HONG KONG, Feb. 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company has been selected and will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited, with effect from March 10, 2025.

Get ready for the first-ever ZEISS Live Tech Reveal USA! In less than an hour, explore seven cutting-edge metrology technologies designed to enhance quality across the entire product lifecycle. Plus, score exclusive special offers just for attending! Register: zeiss.com/metrology/tech-reveal

Ultimate Pet NutritionNutra Thrive for Dogs: A Multi-Benefit Dog Supplement For Hip & Joint, Immune, Antioxidant, & Heart Support

SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- On February 15, 2025,Sanyou Bio conducted a full review of its Intelligent Super-trillion Molecule Discovery Platform. As the core technology of the platform, the intelligent super-trillion molecule library boasts a library capacity of up to 10 trillion, enabling the screening and identification of hundreds to thousands of lead molecules for a single target. By integrating high-through eukaryotic expression verification and multidimensional druggability analysis, the platform significantly improves the efficiency of innovative biological drug R&D and plays a key role in novel macromolecule drug discovery.

Agreement contributes to expanding access to cutting-edge genomic technologies and improving diagnostic efficacy

ORLANDO, Fla., Feb. 21, 2025 /PRNewswire/ -- CR Fitness Holdings LLC., the fastest-growing and leading franchisee of Crunch Fitness, announced the upcoming opening of Crunch Dr. Phillips, a $5 million, 37,080 square-foot state-of-the-art fitness facility. Projected to open in late Fall 2025, Crunch Dr. Phillips is located in the former World of Decor, 7506 Dr. Phillips Blvd.

DOHA, Qatar and NEW YORK, Feb. 23, 2025 /PRNewswire/ -- Deerfield Management today announced a collaboration with Qatar Investment Authority (QIA) as part of QIA's Fund of Funds program.

New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms

SAN DIEGO, Feb. 20, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant and/or traceable to Neumora's registration statement issued in connection with Neumora's initial public offering (the "IPO") held on September 15, 2023, have until April 7, 2025 to seek appointment as lead plaintiff of the Neumora class action lawsuit. Captioned Chang v. Neumora Therapeutics, Inc., No. 25-cv-01072, and pending it the Southern District of New York, the Neumora class action lawsuit charges Neumora as well as certain of Neumora's top executives and directors, and certain underwriters of the IPO, with violations of the Securities Act of 1933.

BROOKLYN, N.Y., Feb. 20, 2025 /PRNewswire/ -- On or about September 19, 2024, Atlantis Operating LLC d/b/a The Phoenix Rehabilitation and Nursing Center ('Phoenix') learned of a data security incident involving a third party vendor, which may have impacted the personal information of current and/or past patients of Phoenix. Phoenix has since diligently worked to determine what happened and what information was involved as a result of this incident. Phoenix, consistent with industry standards, promptly launched an investigation and engaged experts to assist in assessing the scope of the incident. Based on information provided by the third party, it was determined the incident occurred between on or about July 20, 2024. Upon identification of the potentially impacted data set, efforts were then initiated to provide notice to the potentially impacted population.

Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely fueled by the increasing uptake of the influenza vaccine and government efforts to raise awareness and encourage vaccination.

Enhanced Women's Health Program Integrates Pelvic Floor Therapy and Menopause Care Through Partnership with Vira Health

FREMONT, Calif., Feb. 20, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified Service Provider (CSP) Program, designed to expand access to its cutting-edge NULISA assays in academia and biopharmaceutical research.

WINDHAM, N.H., Feb. 20, 2025 /PRNewswire/ --The United States is projected to face a shortage of up to 8,650 cardiologists by 2037, raising serious concerns about access to cardiovascular care. To help healthcare leaders navigate the growing workforce challenge, Medicus Healthcare Solutions has released a new white paper titled An Inside Look at the Cardiology Workforce: Shortages, Demand, and Strategic Responses.

HONG KONG, Feb. 20, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in itsmulticenter, randomized, double-blind Phase III clinical trial of ivonescimab in combination with chemotherapy for first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) (HARMONi-BC1/AK112-308). Ivonescimab is a first-in-class PD-1/VEGF bispecific antibody independently developed by the company.

Auf dem 25. Wellness Congress stellte Nerio Alessandri in Anwesenheit von 2.000 Menschen aus 100 Lndern Healthness vor, die neue Vision, die die Zukunft von Wellness und Prvention revolutionieren wird.

LUND,Sweden, Feb. 21, 2025 /PRNewswire/ --Immunovia will publish its full year 2024 results on February 25, 2025 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com.

Bracco will present an immersive experience at its booth to educate congress attendees on the importance of corporate commitment to sustainability and how its MR imaging portfolio contributes to the progress of sustainable radiology.